Core Viewpoint - Pomerantz LLP is investigating claims on behalf of investors of Charming Medical Limited regarding potential securities fraud or unlawful business practices by the company and its officers or directors [1]. Group 1: Investigation and Legal Actions - The U.S. Securities and Exchange Commission (SEC) issued an order to halt trading of Charming Medical securities due to potential manipulation through social media recommendations aimed at artificially inflating the price and trading volume of the company's securities [3]. - Trading in Charming Medical's securities was suspended starting on November 12, 2025, following the SEC's order [3]. Group 2: Pomerantz LLP Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of over 85 years in fighting for the rights of victims of securities fraud and corporate misconduct [4]. - The firm has successfully recovered numerous multimillion-dollar damages awards on behalf of class members [4].
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Charming Medical Limited - MCTA